Mark Pegram, MD
Consultant: Aventis Pharmaceuticals Inc,
Genentech Inc, ChromaVision
Edith A Perez, MD
Grants/Research Support: Bristol-Myers Squibb
Company, Genentech Inc, Aventis Pharmaceuticals
Inc, Pharmacia Corporation |
Michael F Press, MD, PhD
Speakers' Bureau: Abbott-Vysis, Genentech Inc
Ann D Thor, MD
Consultant: Genentech Inc |
This educational activity contains discussion of published and/or investigational
uses of agents that are not indicated by the FDA. NL Communications Inc
does not recommend the use of any agent outside of the labeled indications.
Please refer to the official prescribing information for each product
for discussion of approved indications, contraindications and warnings.
The opinions expressed are those of the presenters and are not to be
construed as those of the publisher or grantor.
| Additional Faculty (From Breast Cancer Update Audio Series) |
Harold J Burstein, MD, PhD
Assistant Professor of Medicine, Dana Farber Cancer
Institute, Harvard Medical School
Melody Cobleigh, MD
Professor of Medicine, Rush Medical College
Director, Comprehensive Breast Center of Rush-
Presbyterian – St. Luke’s Medical Center
Clifford Hudis, MD
Chief, Breast Cancer Medicine Service, Solid Tumor
Division, Memorial Sloan-Kettering Cancer Center
Nicholas Robert, MD
Chairman of Research, Inova Fairfax Hospital
Cancer Center
Chairman, Breast Committee of the US Oncology
Research Network
Dennis Slamon, MD, PhD
Professor of Medicine, Department of Medicine,
UCLA School of Medicine
Chief, Division of Hematology-Oncology, David
Geffen School of Medicine, UCLA |
George Sledge, MD
Professor of Medicine & Pathology, Ballve-Lantero
Professor of Oncology
Indiana University School of Medicine
Vice Chairman, Eastern Cooperative Oncology Group
Breast Cancer Committee
Member, FDA Oncology Drug Advisory Committee
Member, Department of Defense Breast Cancer
Research Program Integration Panel
Debu Tripathy, MD
Professor of Medicine
Director, Komen/UTSW Breast Cancer Research
Program
University of Texas Southwestern Medical Center at Dallas
Charles Vogel, MD, FACP
Clinical Professor, Sylvester Comprehensive Cancer
Center, University of Miami School of Medicine
Private Breast Medical Oncology Practice
Eric P Winer, MD
Director, Breast Oncology Center, Dana-Farber
Cancer Institute
Associate Professor of Medicine, Harvard Medical
School |
| As a provider accredited by the ACCME, it is the policy of NL Communications
Inc to require the disclosure of any significant financial interest
or any other relationship the sponsor or faculty members have with
the manufacturer(s) of any commercial product(s) discussed in an
educational presentation. The presenting faculty reported the following: |
Harold J Burstein, MD, PhD
Grants/Research Support: Genentech Inc
Melody Cobleigh, MD
Grants/Research Support: Genentech Inc, Agouron
Pharmaceuticals Inc, Amgen Inc, Aventis
Pharmaceuticals Inc, Bristol-Myers Squibb
Company, Coley Pharmaceuticals, Genentech Inc,
Genta Inc, Immunicon Corporation, Novartis
Pharmaceuticals Corporation, SmithKline Beecham
Speakers’ Bureau: Genentech Inc
Clifford Hudis, MD
Grants/Research Support, Consultant, Speakers’
Bureau: AstraZeneca Pharmaceuticals LP,
Genentech Inc
Nicholas Robert, MD
Grants/Research Support: Bristol-Myers Squibb
Company, Genentech Inc, Roche Laboratories Inc
Consultant: Bristol-Myers Squibb Company,
Genentech Inc, AstraZeneca Pharmaceuticals LP
Honorarium: Bristol-Myers Squibb Company,
AstraZeneca Pharmaceuticals LP |
Dennis Slamon, MD, PhD
Speakers' Bureau: Genentech Inc, Aventis
Pharmaceuticals Inc
George Sledge, MD
No financial interests or affiliations to disclose
Debu Tripathy, MD
Consultant: Roche Laboratories Inc
Honorarium: Genentech Inc
Charles Vogel, MD, FACP
Grants/Research Support, Consultant, Speakers’
Bureau: Genentech Inc, GlaxoSmithKline, Amgen
Inc, Aventis Pharmaceuticals Inc, Roche
Laboratories Inc, AstraZeneca Pharmaceuticals LP,
Ortho Biotech, Pharmacia Corporation, Coley
Pharmaceuticals
Eric P Winer, MD
Grants/Research Support: Bristol-Myers Squibb
Company, Genentech Inc, AstraZeneca
Pharmaceuticals LP, GlaxoSmithKline
Bureau: GlaxoSmithKline, Genentech Inc |
|
|
